LEADER 01344nam  2200445   450 
001 9910583072203321
005 20220111170638.0
010   $a0-12-814927-2
010   $a0-12-814926-4
035   $a(CKB)4100000004376114
035   $a(MiAaPQ)EBC5402111
035   $a(PPN)233902821
035   $a(EXLCZ)994100000004376114
100   $a20180619d2018      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aMedical innovation $econcept to commercialization /$fedited by Kevin E. Behrns, Bruce Gingles, Michael G. Sarr
210  1$aLondon, United Kingdom :$cAcademic Press, An imprint of Elsevier,$d[2018]
210  4$dİ2018
215   $a1 online resource (288 pages)
606   $aMedical innovations
606   $aBiomedical Engineering
606   $aTranslational Research, Biomedical
615  0$aMedical innovations.
615  2$aBiomedical Engineering.
615  2$aTranslational Research, Biomedical
676   $a610.90501
702   $aBehrns$b Kevin E.
702   $aGungle$b Bruce
702   $aSarr$b Michael G.$f1950-
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583072203321
996   $aMedical innovation$91932361
997   $aUNINA